Marc Douaisi

560 total citations
15 papers, 456 citations indexed

About

Marc Douaisi is a scholar working on Molecular Biology, Immunology and Virology. According to data from OpenAlex, Marc Douaisi has authored 15 papers receiving a total of 456 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Immunology and 5 papers in Virology. Recurrent topics in Marc Douaisi's work include HIV Research and Treatment (5 papers), Immune Cell Function and Interaction (5 papers) and T-cell and B-cell Immunology (3 papers). Marc Douaisi is often cited by papers focused on HIV Research and Treatment (5 papers), Immune Cell Function and Interaction (5 papers) and T-cell and B-cell Immunology (3 papers). Marc Douaisi collaborates with scholars based in United States, France and Netherlands. Marc Douaisi's co-authors include Ravi S. Kane, Étienne Decroly, M Courcoul, Gilles Bessou, Robert Vigne, Jonathan S. Dordick, Indrani Banerjee, Dhananjoy Mondal, Robert J. Linhardt and Fuming Zhang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Angewandte Chemie International Edition and The Journal of Immunology.

In The Last Decade

Marc Douaisi

15 papers receiving 450 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marc Douaisi United States 11 179 136 128 116 116 15 456
Armando Stano Switzerland 12 387 2.2× 191 1.4× 151 1.2× 109 0.9× 474 4.1× 13 906
Yiming Cao China 11 254 1.4× 82 0.6× 70 0.5× 57 0.5× 119 1.0× 19 444
Roy W. Johnson United States 6 246 1.4× 126 0.9× 123 1.0× 155 1.3× 154 1.3× 8 516
Kenji Kanbara Japan 10 273 1.5× 236 1.7× 167 1.3× 45 0.4× 245 2.1× 14 701
Fiona Fernandes United States 12 190 1.1× 84 0.6× 169 1.3× 445 3.8× 93 0.8× 18 676
Alessia Liguori Italy 10 293 1.6× 48 0.4× 104 0.8× 66 0.6× 179 1.5× 19 631
Kiyomitsu Katsumata Japan 12 118 0.7× 42 0.3× 81 0.6× 253 2.2× 152 1.3× 18 594
Thakshila Amarasena Australia 14 103 0.6× 175 1.3× 136 1.1× 168 1.4× 315 2.7× 21 585

Countries citing papers authored by Marc Douaisi

Since Specialization
Citations

This map shows the geographic impact of Marc Douaisi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Douaisi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Douaisi more than expected).

Fields of papers citing papers by Marc Douaisi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc Douaisi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Douaisi. The network helps show where Marc Douaisi may publish in the future.

Co-authorship network of co-authors of Marc Douaisi

This figure shows the co-authorship network connecting the top 25 collaborators of Marc Douaisi. A scholar is included among the top collaborators of Marc Douaisi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc Douaisi. Marc Douaisi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Douaisi, Marc, Elena E. Paskaleva, Li Fu, et al.. (2024). Synthesis of bioengineered heparin chemically and biologically similar to porcine-derived products and convertible to low MW heparin. Proceedings of the National Academy of Sciences. 121(14). e2315586121–e2315586121. 16 indexed citations
2.
Gupta, Mamta, Matthew Wong, Kamran Jawed, et al.. (2022). Isobutanol production by combined in vivo and in vitro metabolic engineering. Metabolic Engineering Communications. 15. e00210–e00210. 8 indexed citations
3.
Baytaş, Sultan Nacak, Weihua Jin, Yanlei Yu, et al.. (2021). Preparation of Low Molecular Weight Heparin from a Remodeled Bovine Intestinal Heparin. Journal of Medicinal Chemistry. 64(4). 2242–2253. 12 indexed citations
4.
Martin, Jacob T., et al.. (2018). Synthesis of multivalent polymer–aptamer conjugates with enhanced inhibitory potency. International Journal of Nanomedicine. Volume 13. 5249–5253. 5 indexed citations
5.
Douaisi, Marc, Maho Nagasawa, Joshua Craft, et al.. (2017). CD31, a Valuable Marker to Identify Early and Late Stages of T Cell Differentiation in the Human Thymus. The Journal of Immunology. 198(6). 2310–2319. 37 indexed citations
6.
Douaisi, Marc, et al.. (2016). Sphingosine-1-phosphate/sphingosine-1-phosphate receptor 1 signaling is required for migration of naive human T cells from the thymus to the periphery. Journal of Allergy and Clinical Immunology. 138(2). 551–557.e8. 21 indexed citations
7.
Kwon, Seok‐Joon, Dong Hee Na, Jong Hwan Kwak, et al.. (2016). Nanostructured glycan architecture is important in the inhibition of influenza A virus infection. Nature Nanotechnology. 12(1). 48–54. 125 indexed citations
8.
Boggara, Mohan, Ronak Maheshwari, Manish Arha, et al.. (2014). Design of Monodisperse and Well‐Defined Polypeptide‐Based Polyvalent Inhibitors of Anthrax Toxin. Angewandte Chemie International Edition. 53(31). 8037–8040. 15 indexed citations
9.
Banerjee, Indrani, Marc Douaisi, Dhananjoy Mondal, & Ravi S. Kane. (2012). Light-activated nanotube–porphyrin conjugates as effective antiviral agents. Nanotechnology. 23(10). 105101–105101. 57 indexed citations
10.
Douaisi, Marc, Indrakant V. Borkar, Lillian Lee, et al.. (2012). Perhydrolase-nanotube paint composites with sporicidal and antiviral activity. Applied Microbiology and Biotechnology. 97(19). 8813–8821. 19 indexed citations
11.
Legrand, Nicolas, Raphaël Ho Tsong Fang, Marc Douaisi, et al.. (2012). A doxycycline-dependent human immunodeficiency virus type 1 replicates in vivo without inducing CD4+ T-cell depletion. Journal of General Virology. 93(9). 2017–2027. 7 indexed citations
12.
Douaisi, Marc, M Courcoul, Gilles Bessou, et al.. (2005). The tyrosine kinases Fyn and Hck favor the recruitment of tyrosine-phosphorylated APOBEC3G into vif-defective HIV-1 particles. Biochemical and Biophysical Research Communications. 329(3). 917–924. 18 indexed citations
13.
Douaisi, Marc, et al.. (2004). HIV-1 and MLV Gag proteins are sufficient to recruit APOBEC3G into virus-like particles. Biochemical and Biophysical Research Communications. 321(3). 566–573. 82 indexed citations
14.
Douaisi, Marc, et al.. (2004). APOBEC3G Ubiquitination by Nedd4-1 Favors its Packaging into HIV-1 Particles. Journal of Molecular Biology. 345(3). 547–558. 8 indexed citations
15.
Courcoul, M, Gilles Bessou, Marc Douaisi, et al.. (2004). The Vif protein of human immunodeficiency virus type 1 is posttranslationally modified by ubiquitin. Biochemical and Biophysical Research Communications. 315(1). 66–72. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026